Have heart disease? Alcohol may help you avoid a heart attack

Publicly released:
International
CC:0
CC:0

Drinking up to 105 grams of alcohol a week - the same as just under six pints of mid-strength or just over a bottle of wine - could be associated with a decreased risk of having a heart attack, stroke, angina or death among people with heart disease, say UK researchers. The team found people with heart disease that drank up to 15 grams of booze a day - around a half pint or half glass of wine - had a lower risk of recurrent heart attack, stroke, angina or death, compared to those who didn't drink. Additionally, they say that they found the same correlation with people who drank more than 62 grams of alcohol per day - about a half bottle of wine. The team says that while the above is true, the lowest risks were seen in those who drank only six grams of alcohol, compared to people who didn't drink. This kind of study cannot prove that if you have heart disease you should go crack a fresh coldie, but rather that if you exclude all of the other issues around alcohol, you may need to not completely cut out getting on the beers.

Media release

From: Springer Nature

Drinking up to 105 grams of alcohol per week – equivalent to 13 UK units of alcohol, less than six pints of medium-strength beer or just over a bottle of wine – may be associated with a decreased risk of heart attack, stroke, angina or death among those with cardiovascular disease (CVD). The findings are published in the open access journal BMC Medicine.

Chengyi Ding, the corresponding author, said: “Our findings suggest that people with CVD may not need to stop drinking in order to prevent additional heart attacks, strokes or angina, but that they may wish to consider lowering their weekly alcohol intake. As alcohol consumption is associated with an increased risk of developing other illnesses, those with CVD who do not drink should not be encouraged to take up drinking.”

Researchers from UCL, UK found that, among people with CVD, those who drank up to 15 grams of alcohol per day – equivalent to less than two UK units, with one unit equal to half a pint of medium-strength beer or half a standard glass of wine – had a lower risk of recurrent heart attack, stroke, angina or death, compared to those who did not drink. They also found that those who drank more than 62 grams of alcohol per day – equivalent to less than eight UK units – did not have an increased risk of recurrent heart attack, stroke, angina or death, compared to those who did not drink alcohol.

While drinking up to 15 grams of alcohol per day was associated with lower risks of heart attack, stroke, angina or death, the researchers found that those with the lowest risk drank between six and eight grams of alcohol per day – equivalent to less than one UK unit. Those who drank six grams of alcohol per day had a 50% lower risk of recurrent heart attack, angina or stroke than those who did not drink. Those who drank eight grams per day had a 27% lower risk of death due to heart attack, stroke or angina, and those who drank seven grams per day had a 21% lower risk of death due to any cause, compared to those who did not drink.

The authors estimated the risk of heart attack, stroke, angina and death for 48,423 adults with CVD, utilising data obtained from the UK Biobank, the Health Survey for England, the Scottish Health Survey and from 12 previous studies. Participants reported their average alcohol consumption and data on subsequent heart attacks, strokes, angina or death, over a period of up to 20 years, were obtained from health, hospital admission and death registry records.

The authors caution that their findings may overestimate the reduced risk of recurrent heart attack, stroke, angina and death for moderate drinkers with CVD. This is due to the under-representation of heavy drinkers and categorisation of former drinkers who may have quit drinking due to ill health as non-drinkers in some of the datasets included in their analyses.

Journal/
conference:
BMC Medicine
Research:Paper
Organisation/s: University College London, UK
Funder: This work was supported by the Economic and Social Research Council (ES/ K000357/1), the National Institute for Health Research (NIHR) Blood and Transplant Research Unit in Donor Health and Genomics (NIHR BTRU-2014- 10024), UK Medical Research Council (MR/L003120/1), British Heart Foundation (SP/09/002, RG/13/13/30194, RG/18/13/33946), and the NIHR Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The funding bodies had no role in the design of this study, the collection, analysis, and interpretation of the data, or in writing the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.